Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
09/2003
09/24/2003CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6623914 Method for preparing an acid salt of p-phenylenediamine-type photographic color developers
09/18/2003WO2003076393A1 Salts of nateglinide
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003US20030173251 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions
09/18/2003US20030172471 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds
09/18/2003US20030172470 Intense, stable blue color shades can be obtained in addition to natural and purple or violet shades.
09/18/2003CA2478599A1 Salts of nateglinide
09/17/2003EP1344767A2 Choline acids as feedstuff supplement in animal feeeding
09/17/2003EP0970066B1 Preparation of aminoepoxides from aminoaldehydes and an in situ formed halomethyl organometallic reagent
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1442403A Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine
09/16/2003US6620960 Process for the preparation of substituted phenylacetonitriles
09/16/2003US6620845 For therapy and prophylaxis of neurological diseases
09/16/2003US6620418 Antiseptic/antifungal agent and endermic liniment composition which contains it
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2002022550A3 Chiral amino alcohols and process for preparation of same
09/11/2003US20030171621 Process for the synthesis of sphingosine
09/11/2003US20030171612 Method of preparing retroviral protease inhibitor intermediates
09/11/2003US20030171592 A nitro ketone or a cyano ketone is reacted with a hydrogen-donor in the presence of a transition metal compound catalyst having an optically active nitrogen asymmetric ligand to form the alcohol and reducing to the amine
09/11/2003US20030171210 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
09/11/2003US20030170342 Choline acids as feed additive in animal nutrition
09/10/2003EP1341757A1 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
09/10/2003EP1147075B1 Method for producing l-phenylephrine hydrochloride
09/10/2003EP1037592B1 New developer combinations for oxidation colouring agents
09/10/2003CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441771A Method for producing 3,3-diarylpropylamines
09/10/2003CN1441698A Nickel-rhenium catalyst for use in reductive amination process
09/09/2003US6617414 Polymerizable to polybenzothiazoles and polybenzoxazoles; storage stability; high strength, heat resistant fibers and films; white particles of specific size
09/04/2003WO2003072540A1 Novel pseudoceramides and cosmetic compositions comprising the same
09/04/2003WO2003072246A2 Supported silver catalyst and an epoxidation process using the catalyst
09/04/2003WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003US20030166978 Novel ruthenium complexes and process for preparing alcoholic compounds using these
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166601 Drug delivery of the nucleic acid into a target tissue or cell, comprising a core complex contains a nucleic acid and complex forming agents, fusion with cell membranes with nuclear uptake; polymeric outer shell
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340743A1 Optically active amine derivative and method of synthesis
09/02/2003US6613944 Process to produce 3-carbon amino alcohol salts
08/2003
08/28/2003WO2003043973A3 Amine phenolic compounds and their use as hardeners and/or accelerators in epoxy coatings
08/28/2003WO2003029169A3 Hydroxypropylamines
08/28/2003US20030162984 Catalyst and a process using the catalyst
08/28/2003US20030162840 Novel process for preparing salmeterol
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
08/27/2003EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents
08/27/2003CN1119320C Process for separation of organic by-products of 3-chloro-2-hydroxypropyl trimethyl ammonium chloride
08/27/2003CN1119319C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1, 4dihydro-2H-3, 1-benzoxazin-2-one
08/21/2003WO2003068727A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE β-PHENYLALANINE DERIVATIVES
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158266 Particularly septic shock
08/21/2003US20030158176 Quaternary ammonium compounds
08/21/2003US20030158152 Protease inhibitors and their pharmaceutical uses
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003EP0883598B1 Use of aminophenol derivatives in oxidative hair dyes
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/19/2003US6608228 Fluorenyl and dibenzosuberenyl moieties; efficient
08/14/2003WO2003066572A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003US20030153774 Process for the preparation of citalopram
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003CA2475349A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/13/2003EP1334082A2 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
08/13/2003EP1334067A1 Method for the production of form-selective catalysts and use thereof
08/13/2003EP1333795A1 Novel coupler for use in oxidative hair dyeing
08/13/2003EP1333793A1 Novel coupler for use in oxidative hair dyeing
08/13/2003EP0946504B1 Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compounds
08/13/2003CN1436164A Method for producing alkanolamines
08/12/2003US6605744 Reducing dialkyl-protected amino-2-(4alkylphenyl)2-oxoalkyl malonate; treating with basic compound and hydrogenating to produce 2-amino-2-(2-(4-C2-20-alkyl-phenyl)ethyl)propane-1,3-diols such as fingolimod
08/12/2003US6605732 Clean, high-yield preparation of S,S and R,S amino acid isosteres
08/12/2003US6605234 Polysulfide solutions and hydroxalkylaminium ions for stabilizing elemental sulfur
08/07/2003US20030149305 Reacting ammonia with ethylene oxide in presence of zeolite catalyst, wherein temperature controls distribution of alkanolamines
08/07/2003US20030149264 Chiral ionic liquids
08/07/2003US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit
08/07/2003US20030149015 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
08/07/2003US20030145764 P-diaminobenzene derivatives and dyes containing said compounds
08/06/2003EP1331918A1 Primary intermediates for oxidative coloration of hair
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/05/2003US6602900 F-type prostaglandins as ocular hypotensives
08/05/2003US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia
08/05/2003US6602817 Combination approach to chiral reagents or catalysts having amine or amino alcohol ligands
08/05/2003US6602302 Substituted 1,4 diaminobenzene compounds and oxidation dye precursor compositions containing same
07/2003
07/31/2003US20030144531 Preparing chirally pure S-enantiomers of alpha -amino acids comprising the steps of: a) preparing an organometallic reagent from an alkyl halide of the formula (R) 2CH(CH2)nCH2X; b) adding the organometallic reagent to carbon dioxide to form
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003US20030143701 Processes for producing optically active 2-amino-1-phenylethanol derivatives
07/30/2003EP1331218A1 Process for the preparation of protected 3-amino-1,2-dihydroxy-propane acetal and derivatives thereof
07/30/2003CN1433478A Novel colloid synthetic vectors for gene therapy
07/29/2003US6600075 Preparing tertiary amine compounds from primary amines and nitrites in the presence of hydrogen gas and a metal catalyst, or metal-containing catalyst composition, at a temperature from about 50 degrees C. to about 200 degrees C.
07/29/2003US6600074 Perfluoroalkylated aniline compound and process for producing the same
07/24/2003WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
07/24/2003US20030139623 Catalyzing the decarboxylation and hydroxylation in the presence of an aqueous base and a phase transfer catalyst
07/23/2003EP1328504A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
07/23/2003EP0628044B1 Therapeutic nucleosides
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/17/2003WO2003057164A2 Compounds for delivering substances into cells
07/17/2003US20030135052 In the presence of hydrogen gas and a metal catalyst; tertiary amines, such as bis(3-hydroxypropyl)methylamine or bis(5-cyanopentyl)2-hydroxyethyl- or -methylamine
07/17/2003US20030134423 Lipid aggregates (liposomes) for transfection of nucleic acids
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 116